Biotech · Private company · Boulder, CO, US
SomaLogic, Inc.
SEC CIK 0001837412
Track this companyFree. Adds SomaLogic, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Clinical Utility Trial for the SomaLogic CVD-T2D TestNA · COMPLETED · started Mar 15, 2022ClinicalTrials.gov NCT05237271 · fetched Nov 12, 2026
- SomaSignal Tests on Medical Management and Change in Risk in Patients With DiabetesNA · COMPLETED · started Feb 3, 2022ClinicalTrials.gov NCT05256706 · fetched Nov 12, 2026
- Pragmatic Impact of Proteomic Risk Stratification in Diabetes MellitusNA · COMPLETED · started Jan 26, 2022ClinicalTrials.gov NCT05182359 · fetched Nov 12, 2026
- Impact of SomaSignal Tests on the Choice of Glucose-lowering MedicationsNA · COMPLETED · started Jan 1, 2022ClinicalTrials.gov NCT05166382 · fetched Nov 12, 2026
- Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation StudyNA · TERMINATED · started Aug 12, 2021ClinicalTrials.gov NCT04836117 · fetched Nov 12, 2026
- Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular RiskCOMPLETED · started Jun 13, 2017ClinicalTrials.gov NCT03599531 · fetched Nov 12, 2026